Page 2 - Jon Yu News Today

– Ownership of proprietary sourcing for U.S.-manufactured lead SQore excipients allows for full control over supply chain and greater flexibility to...

Disease-modifying candidate UB-312 demonstrated target engagement of aggregated alpha-synuclein in cerebrospinal fluid of Parkinson’s patients Data provide validation of the Vaxxinity platform’s...

UB-312 was immunogenic in patients with early Parkinson’s disease. UB-312 was generally safe and well-tolerated. Results are consistent with conclusions from Phase 1 Part A and preclinical studies, and support advancement of UB-312 into further cl...

- Significant progress in Comera's ongoing research collaboration with Regeneron, a leading U.S. biotechnology company - - Further development of Comera's pipeline candidate CLS-001 (SQ vedolizumab),

CAPE CANAVERAL, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...

CAPE CANAVERAL, Fla., May 09, 2023 -- Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the first... | May 9, 2023

Its too big for the headline - Turn-based, dungeon-crawling RPG Mon-Yu is coming West on PS5. It was previously announced...

Paige Prostate Suite and Breast Lymph Node solutions will be deployed and evaluated at UMC Utrecht UMC Utrecht, one of the largest hospitals in the Netherlands, was one of the first in the world

NEVE ILAN, Israel, Sept. 08, 2022 -- NANO-X IMAGING LTD , an innovative medical imaging technology company, today announces that Company management will participate in two investor... | September 8, 2022

Custom platform tailored to needs of market leader in clinical diagnostics to facilitate better integration, collaboration and workflows for faster diagnosis; better patient and staff experienceNEW YORK--(BUSINESS WIRE)--Paige, a global leader in clinical AI applications for pathology, today announced it will partne...